Donald Trump’s phased tariff plan on imported generic drugs gives companies two years before steep duties begin, raising concerns for India’s pharmaceutical exporters, supply chains, and the future of ...
What’s next for continuous glucose monitoring by 2030 as AI, smarter sensors, and automated insulin delivery promise to transform diabetes care while expanding CGM use beyond traditional glucose manag ...
Discover the best healthcare CRM platforms in 2026, compare their features, security, AI capabilities, and pricing value, and learn which solution works best for hospitals, clinics, and healthcare org ...
.png){kind=logo}
